Rocket Pharmaceuticals- Warrants (02/09/2026) Intangible Assets

As of the most recent data (June 2026), RCKTW shows a intangible assets of $25M. That compares with $25M in the prior-year period — up 0.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RCKTW's intangible assets is now $25M (was $25M) — essentially flat versus a year earlier. Pairing that YoY change with peer averages gives a clearer picture of whether Rocket Pharmaceuticals- Warrants (02/09/2026) is outperforming or lagging.

Tracking RCKTW's intangible assets over time shows whether Rocket Pharmaceuticals- Warrants (02/09/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $25M That compares with $25M in the prior-year period — up 0.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Rocket Pharmaceuticals- Warrants (02/09/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $25M) with ownership activity and broader fundamentals.

Rocket Pharmaceuticals- Warrants (02/09/2026)'s intangible assets is $25M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.